explore -WSS

explore

author：fashion 2025-08-04 12:36:00 - browse：942

Nick Leschly - Bluebird Bio — Longtime Bluebird Bio CEO Nick Leschly Wendy Maeda/The Boston Globe

Some two years after splitting biotech company Bluebird Bio into two entities in a bid to “sharpen their focus” and improve operations, the spinout focused on oncology treatments announced major cost cuts and is parting ways with its chief executive.

The spinout, 2Seventy Bio, announced Tuesday that it is cutting approximately 40% of its workforce, or about 176 employees. It also plans to allocate less money to a couple of drug candidates, including one that is currently on hold with the Food and Drug Administration. The cuts extend the company’s cash runway into 2026.

The company was formed in 2021 when the team behind Bluebird Bio decided to split its drug pipeline down the middle. The company was wrestling with its gene therapy portfolio, including getting approval for a gene therapy for the blood disorder beta thalassemia in the U.S. Separately, it had a basket of cancer drug candidates and a partnership with pharma company Bristol Myers Squibb that needed attention. So, Bluebird split its operations in two, with longtime CEO Nick Leschly taking the helm at the new firm.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Change Healthcare: What is it, why does its cyberattack matter?

hotspot

WSS

A new approach to psychiatric drug development

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

Medicare drug price negotiation hearing pits pharma v Biden admin

Lessons Learned: This is why you network to find that industry job you want

For AI in health care standards, federal regulators join with industry group

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

leisure time

explore

Wikipedia

Duchenne breakthrough therapy leaves behind pioneering families

Discs beat pads, tampons for heavy menstrual flow, new study shows

George Santos makes 1st court appearance after pleading not guilty to 13 counts

IVF doctors demand details after CooperSurgical lawsuit

Novavax promises a turnaround & Lilly roils the obesity market

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

The high cost of giving birth even with insurance

Biden's 'march

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Harvard's David Sinclair gets blowback over aging

entertainment

Choosing scientific sides in the fight against Alzheimer's

IVF doctors demand details after CooperSurgical lawsuit

The public health thinking behind the CDC’s new Covid guidance

Germany receives 178 compensation applications from gay servicepeople over discrimination

Sage's campaign to raise awareness of postpartum depression hits a nerve

‘The Bear’ and hospitality in hospitals

explore

hotspot

hotspot

hotspot